Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 17, 2019

Study Completion Date

June 17, 2019

Conditions
Dry EyeSjogren's SyndromeAqueous Tear DeficiencyMeibomian Gland DysfunctionDry Eye Syndromes
Interventions
DEVICE

Ocular Repetitive Magnetic Stimulation (RMS) treatment

"First stage: Patients will be asked to undergo a one-time treatment with Epitech Corneal Magnetic Stimulation Device on one eye. The worst eye will be treated; if both eyes are equal, the right eye will be treated.~Second stage: will be treated on both eyes, applying treatment to both eyes sequentially during the same visit."

Trial Locations (3)

Unknown

E. Wolfson Medical Center, Holon

Hadassah Medical Center, Jerusalem

Shaare Zedek Medical Center (SZMC), Jerusalem

All Listed Sponsors
lead

Epitech Mag Ltd.

INDUSTRY

NCT03012698 - Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye | Biotech Hunter | Biotech Hunter